Short-Term and Long-Term Efficacy and Safety of Pemetrexed and Tislelizumab in Advanced Epidermal Growth Factor Receptor Tumor Protein 53 Co-Variant Lung Adenocarcinoma.
Autor: | LI LI1, YANXING ZHU1, WEI LU1, WEI LIN1, NANBIAN GUO1, MINBIAO CHEN2 Chenminbiaogod@126.com |
---|---|
Zdroj: | Indian Journal of Pharmaceutical Sciences. 2022 Special Issue4, Vol. 84, p92-98. 7p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |